CORRECTED-UPDATE 1-PharmaMar says paper in journal Science confirms drug's efficacy
Shares in Spanish pharmaceutical company PharmaMar spiked over 20% on Tuesday after it cited a paper published by peer-reviewed journal Science that confirmed "potent preclinical efficacy" of its drug Aplidin against COVID-19.